早期胃癌行内镜粘膜下剥离术应用研究

分别选取进行ESD治疗和外科手术的EGC患者分成标准组和对照组,观察术中并发症情况,并定期随访患者病灶有无残留和复发。结果经治疗和随访后,标准组中术后出现出现和穿孔2例,对照组中术后出现出现和穿孔10例,差异显著(P<0.05),两组患者随访2年后,均为发现术后病灶残留或复发。内镜粘膜下剥离术是治疗早期胃癌的一种安全有效的方法,可以进行推广。

AIDS Treatments Efficiency Analysis Based on Cost Efficiency Data Envelopment Analysis Model

Three data envelopment analysis (DEA) models were used to analyse the relative efficiencies of four AIDS treatments in AIDS Clinical Trial Group (ACTG) Study 193A(1 309 patients in total, classified into 4 age groups). Results from the output-oriented BCC model show that Treatment 4 ( 600 mg of zidovudine plus 400 mg of didanosine plus 400 mg of nevirapine) is particularly efficient for age group 14—25, but not efficient for the older age groups; Treatment 1 (600 mg of zidovudine alternating monthly with 400 mg of didanosine)and Treatment 2 (600 mg of zidovudine plus 2.25 mg of zalcitabine) are efficient for the age groups 35—45 and 45— ; age group 25—35 does not have a particularly efficient treatment, but Treatments 1 and 2 are relatively good. The cost efficiency BCC model, which takes the treatment cost into account, gives similar results as the output-oriented model. Results from the indirect output-oriented BCC model, which allows the replacement among medicines, show that the efficiency of Treatment 2 has greatly decreased compared with that of the output-oriented model, and a set of optimal medicine amounts for different age groups is obtained.

Quality of life and cost-effectiveness of combined therapy for reflux esophagitis

Objectiv e: To evaluate clinical,Quality of Life (QoL) and medical cost outcomes in pati ents with symptomatic reflux esophagitis (RE) receiving different ″triple c ombin ation therapy″ . Methods: A multicenter medical effectiveness trial conducte d in 10 hospitals of 5 regions in Zhejiang Province. 248 patient-volunteers were ass ig ned to 8 weeks of ″ triple combination therapy″ with Lansoprazole plus Cisapri de and Sucralfate or Ranitidine plus Cisapride and Sucralfate. Main outcomes asses sment included symptoms scale scores,RE severity,QoL at baseline and 8 weeks. Medical cost data were collected with cost analysis questionnaire. Results: (1)M ore Lansoprazole group patients noted RE symptoms resolution than Ranitidine gro up(92.3% vs 78.4%,P<0.01). There was no striking difference between two gro ups in RE healing rate (90.8% vs 82.9%, P>0.05). (2)RE significantly impaire d QoL of patients(P<0.001).Compared with Ranitidine group,QoL in Lansoprazole group had significant improvement (rate of ″good″ QoL 64.5% vs 45.6%,P<0.01). (3)T here w as close correlation between symptomic effectiveness and QoL rating scale in bot h the Lansoprazole and Ranitidine group(P<0.01,r=0.235 and 0.353 respec tively). There were no statistical difference of medical cost between the two groups ( P> 0.05). Conclusion: RE significantly impaired QoL of patients. ″Triple combinati o n therapies″ can significantly improve RE symptoms and QoL. Lansoprazole combin ation therapy was more cost-effective than Ranitidine combination group.

Research on the Feasibility of Engineering Application for Solidified Sludge Landfill

The sludge was landfilled after solidification/stabilization treatment. This technology can solve the problem of much sludge treatment. But the study on engineering application is less common. There is a lack of corresponding research results about equipment, process and treatment effect. According to the above problems, this paper discusses the treatment process combining with sludge solidification/stabilization landfill field in Fuyong Town in Shenzhen City. Furthermore, the strength, moisture content, environmental indexes of treated sludge in field test was carried out in order to monitor the treatment effect. The results showed that the sludge solidification/stabilization equipment can meet the need of large-scale engineering application and the treatment process is relatively simple and the solidified sludge can meet the need of landfill.

Influence of Aloe Gel Enrichment on the Physicochemical, Textural and Sensory Characteristics of Dahi

Aloe gel, derived from Aloe vera plant is well known for its nutraceutical potential, It is available commercially as a juice with poor sensory quality. The therapeutic benefits of Aloe gel could be extended to food products concomitantly improving its acceptability. Dahi/curd is an Asian fermented dairy product that enjoys tremendous mass appeal. The objective of the present study was to formulate dahi enriched with Aloe gel （AG） as a functional ingredient and to study its effect on the quality of dahi. Plain dahi was prepared by addition of 2.5% skimmed milk powder （SMP） and suitable starter to milk. For the preparation of AG enriched dahi, SMP was replaced by AG at different levels （0.1-0.25%）. The products were evaluated for moisture, pH, titrable acidity （TA）, whey syneresis （WS）, total solid content （TS）, water holding capacity （WHC）, total yield （TY）, whiteness index （WI）, and viscosity. Microbial analysis and sensory evaluation were also carried out. Enrichment of dahi with AG was found to improve its quality characteristics by causing a significant reduction in WS and an increase in TA, TS, WHC, TY, WI and viscosity. AG dahi recorded good sensory acceptability. Storage study also indicated AG dahi to perform better in terms of the various parameters studied. The present investigation suggests the feasibility of adding Aloe gel powder as a functional ingredient to dahi to enhance product quality as well as its nutritional and therapeutic potency. It could be commercially exploited as a novel product.

Economic Evaluation of Treating Herpes Zoster with Various Methods of Acupuncture and Moxibustion

OBJECTIVE:To analyze the cost effect of surrounding acupuncture plus electric acupuncture,cotton-sheet moxibustion,puncturing with red-hot needles,tapping plus cupping on herpes zoster.METHODS:Five hundred patients with herpes zoster were randomly divided into group A(surrounding acupuncture plus electric acupuncture),group B(cotton-sheet moxibustion),group C(puncturing with red-hot needles),group D(tapping plus cupping),and group E(Western medicine).The treatment was carried out twice a day in group E and once a day in the other four groups.The curative effect was observed on the 10th day of treatment;the cost was calculated for the five therapies,and the cost-effect ratio(C/E) and increment ratio(△ C/△ E) were analyzed.RESULTS:After the 10-day treatment,there was no statistical difference(P>0.05) in the curative effect among the five groups.Pain being alleviated one day faster than in group E amounted to a saving of RMB 21.90 yuan in group A,a saving of RMB 21.87 yuan in group B,a saving of RMB 26.00 yuan in group C,and a saving of RMB 20.23 yuan in group D.Compared with group C,the values of △ C/△ E were RMB 1.55,2.81,and 0.21 yuan in groups A,B,and D,respectively.CONCLUSIONS:The curative effect in groups A,B,C,and D was similar to that in group E,but the C/E was better than in group E.

Synthetic immunity to break down the bottleneck of cancer immunotherapy

As a result of recent breakthroughs in cancer immunotherapies, unprecedented and durable remission, and even cure, has been reported in some patients. Importantly, this progress has been achieved, not by the induction of immunity, but by the delivery of immunity in the form of engineered antibodies （cAbs） or effector T cells. However, these single-target technologies have failed to result in a therapeutic effect in some patients, and evidence suggests that further advances depend on an effective strategy for coping with cancer heterogeneity and dynamics. A synthetic immunity （SI） strategy is proposed to achieve this goal. The fundamental basis of SI involves the generation of a panel of cAbs and antibody-retargeted CTLs designed to destroy all cell lineages of a cancer with high specificity. This goal can be achieved only when the composition of the cAbs is determined using a systematic approach, i.e., selecting the antigens targeted by the cAbs based on an epitope-tree illustrating the clonal antigen architecture of the cancer. Integration of technologies that increase the epitope breadth, cAb affinity and T cell activity will further enhance the efficacy of SI. Using DNA vectors to express the eAbs will be a safe, effective and affordable solution.

Treatment of osteoporotic vertebral compressive fractures with percutaneous kyphoplasty and oral Zishengukang

OBJECTIVE:To observe the therapeutic effect of percutaneous kyphoplasty(PKP) and oral Zishengukang(ZSGK) for the treatment of osteoporotic vertebral compression fractures(OVCFs).METHODS:Seventy patients were randomly divided into a control group(PKP group) and an experimental group(PKP plus ZSGK group).The 35 patients in the experimental group were prescribed 6 g oral ZSGK three times a day for 90 days after PKP.Visual analog pain scale(VAS),Oswestry functional score,vertebral height and Cobb's angle were recorded and compared before treatment and at one week,one month and three months after treatment.RESULTS:Vertebral height and Cobb's angle significantly improved and VAS and Oswestry functional score were significantly lower in both groups after PKP than pre-operatively(P<0.01).Three months after treatment,VAS and Oswestry functional score in the experimental group were lower than controls(P<0.05),even though vertebral height and Cobb's angle were comparable(P>0.05).CONCLUSION:PKP combined with oral ZSGK provide superior short-term and long-term symptom control after OVCF than PKP alone.